Emotional outcome of adolescents and young adults with early and continuously treated phenylketonuria
- PMID: 11700332
- DOI: 10.1093/jpepsy/26.8.477
Emotional outcome of adolescents and young adults with early and continuously treated phenylketonuria
Abstract
Objective: To assess the emotional functioning of adolescents and young adults with early and consistently treated phenylketonuria (PKU).
Methods: Twenty PKU-affected participants, ages 14-25, were compared with age-matched chronically ill (n = 17) and peer (n = 16) controls on a structured clinical interview, the Minnesota Multiphasic Personality Inventory, and the Tennessee Self-Concept Scale-2. Affected participants and nonparticipants were assessed using a multidomain assessment of functioning interview.
Results: There were no significant differences between groups for observable psychiatric disorders or emotional and functional symptoms. No significant differences were found in self-concept. Although there were no differences between groups for IQ or treatment variables, PKU-affected participants were more likely than nonparticipants to have sought help for psychological concerns.
Conclusions: Results suggest that early-treated PKU-affected adolescents and young adults do not show a higher risk for psychological disturbance than appropriate controls.
Similar articles
-
Neurocognitive functioning in adults with phenylketonuria: results of a long term study.Mol Genet Metab. 2013;110 Suppl:S44-8. doi: 10.1016/j.ymgme.2013.08.013. Epub 2013 Aug 31. Mol Genet Metab. 2013. PMID: 24071437
-
Psychiatric disorders in adult patients with early-treated phenylketonuria.Pediatrics. 1997 Mar;99(3):345-50. doi: 10.1542/peds.99.3.345. Pediatrics. 1997. PMID: 9041285
-
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.Neuropsychol Rev. 2007 Jun;17(2):91-101. doi: 10.1007/s11065-007-9021-2. Epub 2007 Apr 5. Neuropsychol Rev. 2007. PMID: 17410469
-
Review: emotional and behavioral functioning in phenylketonuria.J Pediatr Psychol. 1999 Jun;24(3):281-99. doi: 10.1093/jpepsy/24.3.281. J Pediatr Psychol. 1999. PMID: 10379143 Review.
-
The role of intelligence in phenylketonuria: a review of research and management.Mol Genet Metab. 2010;99 Suppl 1:S18-21. doi: 10.1016/j.ymgme.2009.10.015. Mol Genet Metab. 2010. PMID: 20123465 Review.
Cited by
-
Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.BMC Public Health. 2014 Dec 4;14:1243. doi: 10.1186/1471-2458-14-1243. BMC Public Health. 2014. PMID: 25471331 Free PMC article.
-
Analysis of gene variation and long-term follow-up in children with phenylalanine hydroxylase deficiency diagnosed by newborn screening.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Dec 7;52(6):701-706. doi: 10.3724/zdxbyxb-2023-0450. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38105703 Free PMC article. Chinese, English.
-
Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.J Inherit Metab Dis. 2017 Nov;40(6):793-799. doi: 10.1007/s10545-017-0082-y. Epub 2017 Aug 23. J Inherit Metab Dis. 2017. PMID: 28836033
-
Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences.Mol Genet Metab. 2012 Dec;107(4):650-8. doi: 10.1016/j.ymgme.2012.08.001. Epub 2012 Aug 8. Mol Genet Metab. 2012. PMID: 22951387 Free PMC article.
-
Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).Health Qual Life Outcomes. 2008 Mar 26;6:25. doi: 10.1186/1477-7525-6-25. Health Qual Life Outcomes. 2008. PMID: 18366761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical